Back
Revance Therapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
4
RVNC
Revance Therapeutics
Last Price:
4.13
Seasonality Move:
7.02%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.
Revance Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.26 | Sell |
| 20-day SMA: | 5.33 | Sell |
| 50-day SMA: | 5.62 | Sell |
| 200-day SMA: | 4.66 | Sell |
| 8-day EMA: | 4.89 | Sell |
| 20-day EMA: | 5.25 | Sell |
| 50-day EMA: | 5.33 | Sell |
| 200-day EMA: | 6.2 | Sell |
Revance Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 22.01 | Sell |
| Chaikin Money Flow: | -4360846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.71 - 5.93) | Sell |
| Bollinger Bands (100): | (3.48 - 6.32) | Sell |
Revance Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Revance Therapeutics Stock
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 3.44 while RVNC 8-day simple moving average is 5.26, which is a Sell signal.
- The stock price of RVNC is 3.44 while Revance Therapeutics 20-day SMA is 5.33, which makes it a Sell.
- Revance Therapeutics 50-day simple moving average is 5.62 while RVNC share price is 3.44, making it a Sell technically.
- RVNC stock price is 3.44 and Revance Therapeutics 200-day simple moving average is 4.66, creating a Sell signal.
RVNC Technical Analysis vs Fundamental Analysis
Sell
4
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy or a Sell?
-
Revance Therapeutics stock is rated a Sell
The current Revance Therapeutics [RVNC] share price is $3.44. The Score for RVNC is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Revance Therapeutics Stock Info
Market Cap:
360.86M
Price in USD:
3.44
Share Volume:
6.2M
Revance Therapeutics 52-Week Range
52-Week High:
9.75
52-Week Low:
2.30
Sell
4
Revance Therapeutics (RVNC)
is a Sell
Revance Therapeutics Share Price Forecast
-
What is the Revance Therapeutics stock price today?
The Revance Therapeutics stock price is 3.44 USD today. -
Will RVNC stock go up or go down?
Revance Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Revance Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Revance Therapeutics is overvalued.
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 3.44 while RVNC 8-day exponential moving average is 4.89, which is a Sell signal.
- The stock price of RVNC is 3.44 while Revance Therapeutics 20-day EMA is 5.25, which makes it a Sell.
- Revance Therapeutics 50-day exponential moving average is 5.33 while RVNC share price is 3.44, making it a Sell technically.
- RVNC stock price is 3.44 and Revance Therapeutics 200-day simple moving average is 6.20, creating a Sell signal.
Fundamental Analysis of Revance Therapeutics
Is Revance Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.63 per share.
Technical Analysis of Revance Therapeutics
Should I short Revance Therapeutics stock?
- RVNC Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting Revance Therapeutics is a Sell
- Revance Therapeutics Relative Strength Index (RSI) is 22.01, which suggest Revance Therapeutics is oversold
- The Bollinger Bands (25) for Revance Therapeutics is (4.71 - 5.93), which suggest Revance Therapeutics is a Sell
- The Bollinger Bands (100) for Revance Therapeutics is (3.48 - 6.32), which suggest Revance Therapeutics is a Sell
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.